Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.23) by 52.17 percent. This is a 5.41 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $11.380 million which missed the analyst consensus estimate of $12.239 million by 7.02 percent.